share_log

Elevai Labs | 8-K: Current report

Elevai Labs | 8-K: Current report

Elevai Labs | 8-K:重大事件
美股SEC公告 ·  2024/11/27 05:38

Moomoo AI 已提取核心信息

Elevai Labs announced a 1-for-200 reverse stock split effective November 27, 2024, aimed at meeting Nasdaq's minimum bid price requirement of $1.00 per share under Listing Rule 5550(a)(2). The split will automatically consolidate every 200 shares of common stock into one share, with shareholders receiving one full share for fractional portions.The company will maintain its "ELAB" trading symbol but receive a new CUSIP number (28622K 203). Post-split, approximately 3.07 million shares of common stock will be outstanding. The company will proportionally adjust outstanding stock awards, options, and the equity incentive plan to reflect the new share structure.CEO Graydon Bensler emphasized that this measure is necessary to preserve Elevai's Nasdaq listing and support continued progress. Shareholders holding shares through brokers will see automatic updates, while certificate holders can exchange their certificates through VStock Transfer, LLC.
Elevai Labs announced a 1-for-200 reverse stock split effective November 27, 2024, aimed at meeting Nasdaq's minimum bid price requirement of $1.00 per share under Listing Rule 5550(a)(2). The split will automatically consolidate every 200 shares of common stock into one share, with shareholders receiving one full share for fractional portions.The company will maintain its "ELAB" trading symbol but receive a new CUSIP number (28622K 203). Post-split, approximately 3.07 million shares of common stock will be outstanding. The company will proportionally adjust outstanding stock awards, options, and the equity incentive plan to reflect the new share structure.CEO Graydon Bensler emphasized that this measure is necessary to preserve Elevai's Nasdaq listing and support continued progress. Shareholders holding shares through brokers will see automatic updates, while certificate holders can exchange their certificates through VStock Transfer, LLC.
Elevai Labs宣布于2024年11月27日进行每200股反向股票拆分,旨在满足纳斯达克上市规则5550(a)(2)中每股最低买盘价格1.00美元的要求。该拆分将自动将每200股普通股合并为一股,股东将为其分数部分获得一整股。该公司将保持其"ELAB"交易标的,但将获得一个新的CUSIP编号(2862.2万 203)。拆分后,约307万股普通股将流通在外。公司将按比例调整已发行的股票奖励、期权以及股权激励计划,以反映新的股票结构。首席执行官Graydon Bensler强调,这一措施对于维持Elevai在纳斯达克的上市地位和支持持续进展是必要的。通过经纪公司持有股份的股东将看到自动更新,而持有证书的股东可以通过VStock Transfer, LLC兑换其证书。
Elevai Labs宣布于2024年11月27日进行每200股反向股票拆分,旨在满足纳斯达克上市规则5550(a)(2)中每股最低买盘价格1.00美元的要求。该拆分将自动将每200股普通股合并为一股,股东将为其分数部分获得一整股。该公司将保持其"ELAB"交易标的,但将获得一个新的CUSIP编号(2862.2万 203)。拆分后,约307万股普通股将流通在外。公司将按比例调整已发行的股票奖励、期权以及股权激励计划,以反映新的股票结构。首席执行官Graydon Bensler强调,这一措施对于维持Elevai在纳斯达克的上市地位和支持持续进展是必要的。通过经纪公司持有股份的股东将看到自动更新,而持有证书的股东可以通过VStock Transfer, LLC兑换其证书。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息